MO4-1 Management of infusion-related reactions in patients receiving amivantamab in the CHRYSALIS study.

التفاصيل البيبلوغرافية
العنوان:	MO4-1 Management of infusion-related reactions in patients receiving amivantamab in the CHRYSALIS study.
المؤلفون:	Park, Keunchil¹ (AUTHOR), Sabari, Joshua² (AUTHOR), Haura, Eric B.³ (AUTHOR), Shu, Catherine A.⁴ (AUTHOR), Spira, Alexander⁵ (AUTHOR), Salgia, Ravi⁶ (AUTHOR), Reckamp, Karen L.⁷ (AUTHOR), Sanborn, Rachel E.⁸ (AUTHOR), Govindan, Ramaswamy⁹ (AUTHOR), Bauml, Joshua M.¹⁰ (AUTHOR), Curtin, Joshua C.¹¹ (AUTHOR), Xie, John¹¹ (AUTHOR), Roshak, Amy¹¹ (AUTHOR), Lorenzini, Patricia¹¹ (AUTHOR), Millington, Dawn¹¹ (AUTHOR), Thayu, Meena¹¹ (AUTHOR), Knoblauch, Roland E.¹¹ (AUTHOR), Cho, Byoung Chul¹² (AUTHOR)
المصدر:	Annals of Oncology. 2022 Supplement 6, Vol. 33, pS482-S482. 1p.
مصطلحات موضوعية:	PUPAE, PATIENTS
قاعدة البيانات:	Academic Search Index

الوصف
تدمد:	09237534
DOI:	10.1016/j.annonc.2022.05.104